Related Experiment Videos

Optimum age for measles immunization in Romania

Virologie
|January 1, 1986
PubMed

Insights

Maternal measles antibodies disappear by 7 months, supporting 9-month measles vaccination. Studies show no difference in antibody response or persistence regardless of vaccination age.

Area of Science:

  • Pediatrics
  • Immunology
  • Public Health

Background:

  • Maternal antibodies wane, impacting infant protection against measles.
  • Optimal timing for measles vaccination is crucial for effective immunization programs.

Purpose of the Study:

  • To evaluate the feasibility of initiating measles vaccination at 9 months of age.
  • To assess maternal antibody persistence and vaccine response in infants.

Main Methods:

  • Serological survey conducted from 1979 to 1985.
  • Investigated maternal antibody persistence in 188 infants (1-8 months).
  • Compared antibody response and antibody persistence in infants vaccinated at different ages.

Main Results:

  • Maternal measles antibodies were undetectable after 7 months of age.
  • No significant difference in antibody response between infants vaccinated at 9-11 months versus those vaccinated after 12 months.
  • No significant difference in vaccine-induced antibody persistence (1-4 years post-vaccination) based on vaccination age.

Conclusions:

  • Initiating measles vaccination at 9 months is a satisfactory age.
  • Study supports the recommendation for early measles immunization in Romania.

Related Concept Videos